# Dexcom to build €300M manufacturing plant in Athenry, Ireland

Dexcom plans to build its first European manufacturing site in Athenry, Galway, Ireland. The facility represents a €300 million investment over five years and could create up to 1,000 jobs.

- Type: New facility
- Announced: 2023-05-05
- Where: Athenry, Galway, Ireland, Ireland
- Value: $330.0M (300.0M EUR)
- Jobs: 1,000
- Starts operating: 2026
- Status: announced
- Capacity: 60 million CGM units annually
- Products: continuous glucose monitoring devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DexCom](https://endata.com/companies/6670.md)

## Sources

- [idaireland.com](https://www.idaireland.com/latest-news/press-release/dexcom-selects-ireland-for-first-european-manufacturing-site), 2023-05-05: "Dexcom, Inc., a global leader in continuous glucose monitoring for people with diabetes, plans to build its newest global manufacturing facility in Athenry, Galway."
- [reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/dexcom-build-its-first-european-factory-ireland-2023-05-05/?taid=6455399d284dd100013d802f), 2023-05-05: "U.S. medical device company Dexcom plans to invest 300 million euros over the next five years to build a manufacturing site in Ireland, creating up to 1,000 jobs."
- [constructionreviewonline.com](https://constructionreviewonline.com/dexcom-to-build-a-new-manufacturing-facility-in-ireland/), 2023-05-08: "Dexcom has officially opened its new €300 million ($325 million) state-of-the-art manufacturing and office facility in Athenry, Co. Galway."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.